Share

May 28, 2013; 80 (22) Special Article

Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease [RETIRED]

Report of the Guideline Development Subcommittee of the American Academy of Neurology

Melissa J. Armstrong, Gary Gronseth, David C. Anderson, José Biller, Brett Cucchiara, Rima Dafer, Larry B. Goldstein, Michael Schneck, Steven R. Messé
First published May 27, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318294b32d
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
19274

Share

This guideline is retired. The recommendations and conclusions are no longer considered valid and no longer supported by the AAN. Retired guidelines should be used for historical reference only. Please see AAN current guidelines here

Footnotes

  • Approved by the Guideline Development Subcommittee on July 14, 2012; by the Practice Committee on August 3, 2012; and by the AAN Board of Directors on January 17, 2013.

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Received August 24, 2012.
  • Accepted in final form January 3, 2013.

Letters: Rapid online correspondence

  • Authors' response to Khoo correspondence
    • Melissa J. Armstrong, Assistant Professor, University of Maryland School of Medicine
    • Melissa J. Armstrong, Baltimore, MD; Jose Biller, Chicago, IL; Larry B. Goldstein, Durham, NC; Michael Schneck, Maywood, IL; Steven R. Messe, Philadelphia, PA
    Submitted June 17, 2013
  • Dental procedure during warfarin
    • Kah Fang Khoo, consultant physician,
    Submitted June 13, 2013
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles